P-285 Clinical significance of platelet associated immunoglobulin G in interferon therapy for chronic hepatitis C
โ Scribed by Yoshiaki Hashimoto; Toshiyuki Otsuka; Hiroaki Nakajima; Kenji Katagai; Emiko Kaneko; Ken Takehara; Toshihiko Yamada; Takayuki Arai; Hitoshi Takagi; Jiro Takezawa; Takeaki Nagamine; Shoji Yamada; Masatomo Mori
- Book ID
- 113402173
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 127 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0928-4346
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Interferon alpha (IFNโฮฑ) therapy is currently the treatment of choice for chronic hepatitis C (HCV) infection, but it fails to achieve a sustained response in approximately 75% of those treated. The factors which determine whether or not an individual will respond to IFNโฮฑ are uncertain
Whether sustained biochemical response and absence of serum HCV RNA in the 6-12 months following suspension of interferon-โฃ (IFN-โฃ) therapy reflect definitive viral clearance in patients with chronic hepatitis C virus (HCV) infection is controversial. To obtain more information on this topic, HCV RN